At the CRUK Centre for Drug Development (CDD) we translate today’s science into tomorrow’s medicine. The academic, pharmaceutical and biotechnology sectors across the globe trust us to realise the full potential of their research. This is why we are the partner of choice for early phase cancer drug development.
Drug discovery and development
Speak to our Clinical Partnerships Team for more information and advice on project applications.
Email the team at firstname.lastname@example.org.
We fund a broad portfolio of investigator-led biotherapeutic and small molecule drug discovery, supported by an extensive core-funded infrastructure including four small molecule Drug Discovery Units and the CRUK-MedImmune Alliance Laboratory.
Clinical Development Partnerships (CDP) is an initiative to increase the number of clinical trials being undertaken for the treatment of cancer.
This is a joint initiative by our Experimental Cancer Medicine Centres and pharmaceutical collaborators to increase the number of clinical trials using new combinations of treatment for cancer.